Prevalence of microalbuminuria among adults with Type 2 Diabetes mellitus at OOUTH, Sagamu

  • Adebayo Adetola Amballi Department of Chemical PathologyOlabisi Onabanjo UniversitySagamu http://orcid.org/0000-0002-7828-7270
  • Olatunde Odusan Department of Medicine, Olabisi Onabanjo University, Sagamu
  • Omobola Abioye Ogundahunsi Department of Chemical PathologyOlabisi Onabanjo UniversitySagamu
  • Alfred Ademola Jaiyesimi Department of MedicineOlabisi Onabanjo UniversitySagamu
  • Sunday Kolawole Oritogun Department of Community Medicine and Primary CareOlabisi Onabanjo UniversitySagamu
  • Wasiu Eniola Olooto Department of Chemical PathologyOlabisi Onabanjo UniversitySagamu
Keywords: Chronic Kidney Disease, Glycated haemoglobin, Hypertension, Microalbuminuria, Obesity, Diabetes mellitus

Abstract

Background: Diabetes mellitus is a serious global epidemic. The menace of this chronic disease is attributable to its chronic complications which threaten both the world economy and life expectancy, especially in Sub- Saharan Africa. Nephropathy is a complication of Diabetes mellitus and a leading cause of End Stage Renal Disease.

Objectives: To determine the prevalence of microalbuminuria as well as the effects of co-morbidities on the pattern of microalbuminuria among adults with Type 2 Diabetes mellitus.

 Methods: A total of 325 adults with Diabetes mellitus and 100 controls without Diabetes mellitus were studied. The subjects with diabetes were classified into four groups ([i] diabetes only, [ii] diabetes with hypertension, [iii] diabetes with obesity and [iv] diabetes with hypertension and obesity). Urinary protein, microalbuminuria, fasting plasma glucose and Glycated Haemoglobin (HbA1c) were measured using standard methods.

Results: The overall prevalence of microalbuminuria was 35.1% in the diabetic population compared to 8.0% in the control group. The prevalence of microalbuminuria in the various diabetic subgroups were as follows: 30.3% (diabetes only), 43.1% (diabetes with hypertension), 37.0% (diabetes with obesity) and 44.6% (diabetes with hypertension and obesity). The fasting plasma glucose and HbA1c were statistically significantly higher in the diabetic population than the control group. This indicated that there is a poor glycaemic control in the diabetic population and hence a possible cause of diabetic nephropathy.

Conclusion: The risk of diabetic nephropathy was significant in the study population. The presence of one or more co-morbidities and poor glycaemic control increased the occurrence of diabetic nephropathy.

References

1. Ogbera AO, Ekpebegh C. Diabetic Mellitus in Nigeria: the past, present and future. World J Diabetes 2014; 5(6): 905–911.
2. International Diabetic Federation. Diabetes: The Global Burden (5th ed) Diabetic Atlas, 2011.
3. Wang C, Li C, Gong W, Lou T. New Urinary Biomarkers for diabetic kidney disease. Biomarkers Research 2013; 1(9): 1–4, DOI: 10.1186/2050-777-1-1-9. http://www.biomarkers.org/contents/1/1/9. Accessed on February 4th 2013.
4. Alebiosu CO, Ayodele OE. The increasing prevalence of diabetic nephropathy as a cause of end stage renal disease in Nigeria. Trop Doct 2006; 36(4): 218 – 219.
5. Otu HH, Can H, Spentzos D, Nelson RG, Hanson RL, Looker, HC, et al. Prediction of diabetic nephropathy using urine proteonic profiling 10years prior to development of nephropathy. Diabetes Care 2007; 30: 638 – 643.
6. Hasslacher CH, Ritz E, Wahl P, Michae C. Similar risk of nephropathy in patients with Type I or Type II Diabetes mellitus. Nephrol Dial Transplant 1989; 4: 859–863.
7. Alebiosu CO, Kadiri S. Clinical review of diabetic nephropathy in Ibadan, Nigeria. A prospective study. Niger Med Pract 2001; 40(1-2): 15–17.
8. Alebiosu CO. Clinical diabetic nephropathy in a tropical African population. West Afr J Med 2003; 22(2): 152–155.
9. Maduka IC, Neboh EE, Kwubiri UN. The prevalence of Diabetic Nephropathy in Diabetic patients. Eur J Sci Res 2009; 26(2): 255–259.
10. Chukwuebuni NJ, Digban AK, Chukwuani U, Yovwin DG. Prevalence and risk factors of Microalbuminuria among Type 2 Diabetics: A hospital – based study from Warri, Nigeria. Sah Med J 2016; 19(1): 16–20.
11. Lebovitz HE. Insulin resistance: definition and consequences http://www.thieme-connect.com /doi/doi:10.10 55/s-2001-185 76. Accessed in February, 2001.
12. Joslin Diabetes Centre. Stay healthy with diabetes, 2016. www.joslin.org
13. Jeffery M. Hypertension Guidelines: Revisiting the JNC 7 recommendations. The Journal of Lancester General Hospital 2008; 3(3): 91 – 97.
14. World Health Organization. WHO Guidelines/ Classification for Obesity. 2011.
15. Rowe DJ, Dawnay A, Watts GF. Microalbuminuria in diabetes mellitus review and recommendations for the measurement of albumin in urine. Ann Clin Biochem 1990; 27(4): 297- 312.
16. Burtis CA, Ashwood ER. Renal function and Nitrogen metabolites: Dipstick testing. Tietz Textbook of Clinical Chemistry. 3rd Ed.1994:1261 – 1262.
17. Barham D, Trinder P. An Improved Colour Reagent for the Determination of Blood Glucose by the Oxidase System. Analyst 1972; 97(151): 142–145.
18. Chinenye S, Young EE. State of Diabetes care in Nigeria: A review. Niger Health J 2011; 11: 101–109.
19. Chinenye S, Ogbera AO. Socio cultural aspects of Diabetes mellitus in Nigeria. J Soc Health 2013; 1(1): 15–21
20. Ibadin MO, Onunu A, Unigbe E. Microalbuminuria in adolescent/young adult offsprings of hypertensive Nigeria adults – A preliminary report. Nig J Clin Pract 2004; 7: 60–64.
21. Okpere AN, Anochie IC, Eke FU. Prevalence of microalbuminuria among secondary school children. Afr Health Sci 2012; 12(2): 140–147.
Published
2018-06-17
Section
Original Research